Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $32.31 billion
- Book Value:
- Revenue TTM:
- $8.72 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $4.81 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Alcon AG had its IPO on 2019-04-09 under the ticker symbol ALC.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Alcon AG has a staff strength of 25,178 employees.
Shares of Alcon AG opened at $70.79 at the start of the last trading session i.e. 2023-03-31.
The stocks traded within a range of $70.25 - $71.3, and closed at $70.54.
This is a -0.37% slip from the previous day's closing price.
A total volume of 2,263,861 shares were traded at the close of the day’s session.
In the last one week, shares of Alcon AG have increased by +5.44%.
Alcon AG's Key Ratios
Alcon AG has a market cap of $32.31 billion, indicating a price to book ratio of 1.7758 and a price to sales ratio of 3.8913.
In the last 12-months Alcon AG’s revenue was $8.72 billion with a gross profit of $4.81 billion and an EBITDA of $1.89 billion. The EBITDA ratio measures Alcon AG's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Alcon AG’s operating margin was 9.68% while its return on assets stood at 1.84% with a return of equity of 1.72%.
In Q4, Alcon AG’s quarterly earnings growth was a positive 5579% while revenue growth was a positive 1%.
Alcon AG’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.69 per share while it has a forward price to earnings multiple of 28.2486 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alcon AG’s profitability.
Alcon AG stock is trading at a EV to sales ratio of 4.3559 and a EV to EBITDA ratio of 20.3406. Its price to sales ratio in the trailing 12-months stood at 3.8913.
Alcon AG stock pays annual dividends of $0.227 per share, indicating a yield of 0.33% and a payout ratio of 9.17%.
Balance sheet and cash flow metrics
- Total Assets
- $29.21 billion
- Total Liabilities
- $2.78 billion
- Operating Cash Flow
- Capital Expenditure
- $255 million
- Dividend Payout Ratio
Alcon AG ended 2023 with $29.21 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $29.21 billion while shareholder equity stood at $19.68 billion.
Alcon AG ended 2023 with $0 in deferred long-term liabilities, $2.78 billion in other current liabilities, 20000000.00 in common stock, $0 in retained earnings and $8.97 billion in goodwill. Its cash balance stood at $980.00 million and cash and short-term investments were $980.00 million. The company’s total short-term debt was $168,000,000 while long-term debt stood at $4.54 billion.
Alcon AG’s total current assets stands at $5.19 billion while long-term investments were $108.00 million and short-term investments were $0.00. Its net receivables were $1.99 billion compared to accounts payable of $861.00 million and inventory worth $2.11 billion.
In 2023, Alcon AG's operating cash flow was $0 while its capital expenditure stood at $255 million.
Comparatively, Alcon AG paid $0.09 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Alcon AG stock is currently trading at $70.54 per share. It touched a 52-week high of $81.7385 and a 52-week low of $81.7385. Analysts tracking the stock have a 12-month average target price of $84.17.
Its 50-day moving average was $71 and 200-day moving average was $68.05 The short ratio stood at 7.89 indicating a short percent outstanding of 0%.
Around 6.3% of the company’s stock are held by insiders while 5995.1% are held by institutions.
Frequently Asked Questions About Alcon AG
Similar Industry Stocks (Medical Instruments & Supplies)
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx laser system, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.